ArticleScientific reports2025
The role of community pharmacy professionals in combating Counterfeit and substandard drugs in the Amhara regional state, Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Counterfeit and substandard drug products pose significant public health challenges, affecting millions of people worldwide in both developed and developing countries. These products compromise healthcare systems, reduce treatment efficacy, and endanger patient safety. Therefore, this study assessed strategies to reduce the circulation of counterfeit and substandard drugs, identify potential factors leading to their circulation and evaluate the role of community pharmacy professionals in combating counterfeit and substandard drugs in Ethiopia. A cross-sectional multi-center survey of community pharmacy professionals in the Amhara region of Ethiopia was conducted over four months, from May to August 2024. Data were collected using a self-administered, pre-tested questionnaire. Descriptive statistics were used to summarize the different variables and are presented in tables and figures. Among the 276 community pharmacy professionals approached, 255 completed the questionnaire, resulting in a response rate of 92.4%. Approximately, 90% of the participants agreed that weak enforcement of drug laws and legislation contributes to the circulation of counterfeit and substandard drugs in the country. As a strategy, 95.7% of the participants believed that strict enforcement and proper implementation of drug laws by pharmacy regulatory agencies can help control counterfeit and substandard drugs. Approximately 85.7% of the participants agreed that educating the public about the risks of counterfeit and substandard drugs and protective strategies is crucial in reducing their circulation. Almost all participants (98%) acknowledged the pharmacist's responsibility to purchase medicines from certified drug sources and distributors. and a similar portion of the participants (96.8%) agreed that pharmacists should report counterfeit and substandard drugs to the regulatory officials. The current study revealed that strict enforcement of drug laws, development of the local pharmaceutical industry, educating the public about counterfeit and substandard drugs, and monitoring online sales of drugs can significantly contribute to combating counterfeit and substandard drugs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.